Presented by:
Sponsored by:
Cleveland Society of Obstetricians and Gynecologists
Topic: Back to the Future
Moderator: Christine M. Slotta, MD
November 20, 2013 1:00-5:00 pm
DoubleTree Hotel at Rockside and I-77
1:00 p.m.
Welcome by Vicki Reed, MD, President
1:05 p.m.
Training for Emergencies: Simulation in Obstetrics
Amanda Kalan, MD
Staff, Section of Maternal Fetal Medicine
Cleveland Clinic
1:45 p.m.
Non-invasive Prenatal Testing: A New Era in Aneuploidy Screening
Jane E. Corteville, MD
Director of MacDonald Imaging
Clinical Geneticist
Case Western Reserve University
2:25 p.m.
Current and Future State of Fetal Therapy
Stephen P. Emery, MD
Associate Professor of Obstetrics, Gynecology and Reproductive Sciences
University of Pittsburgh School of Medicine
Director, Fetal Diagnosis and Treatment Center
Magee –Womens Hospital of UPMC
3:05-3:15 p.m.
Financial update for members/Refreshment break for non-members
3:20-3:35 p.m.
Refreshment Break
3: 35 p.m.
Prophylactic Surgery for BRCA 1 and 2 Positive Patients
Jason Knight, MD
Division of Gynecologic Oncology
Cleveland Clinic
4:15 p.m.
Healthcare Reform: What OB/GYNs Need to Know About Changes in our Healthcare System
Brad Lucas, MD, MBA, FACOG
Chief Medical Officer
Buckeye Community Health Plan
5:00 p.m.
Raffle and Adjourn
LEARNING OBJECTIVES & PROFESSIONAL PRACTICE GAP(S)
After this session, participants will be able to:
1. Describe AHRQ TeamStepps Domains (situation monitoring, mutual support, communication, and
leadership)
2. Identify team strategies and tools to enhance performance and patient safety
3. Review ACOG safety checklists
4. Explain the technology behind NIPT
5. Describe the performance and limitations of the test
6. Delineate when it is applicable
7. Define when invasive testing is needed
8. Discuss a reasonable screening paradigm
9. Outline future directions of the technology
10. Discuss the unique bioethics of fetal therapy
11. Review currently available options for fetal intervention
12. Discuss future direction in the field
13. Explain the indications for prophylactic oophorectomy
14. Realize the extent of dissection required to minimize the risk or remnant gonadal tissue
15. Realize the clinical considerations regarding concurrent hysterectomy
16. Realize and distinguish the role of Medical Homes, Patient-Centered Care Initiatives, and Health Insurance
Exchanges
17. List ways that the Affordable Care Act affects their OB/GYN practice
18. Explain the role of managed care Medicaid in obstetrics in Ohio and how they can utilize the health plan
resources
Practice Gap(s) for this session: The Practice Gap is the reason a conference or CME activity needs to be held. It
describes the difference between where a group of learners/field of study/ practice currently is (current status)
and where the learning/practice should be (desired status). The "gap" between the current and the desired will be
used to identify conference needs, purposes, objectives, and desired outcomes.
1.
2.
3.
4.
Awareness of NIPT and genetic arrays
Awareness of intrauterine fetal surgeries available
Awareness of counseling and treatments available to BRCA+ patients and available tools
Awareness of the shift in training practices and the successes could they could offer
ACCREDITATION
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Case Western Reserve University School of Medicine designates this live activity for a maximum of 3.5 AMA PRA
Category 1 Credit.TM. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
DISCLOSURE
The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director,
planning committee members and all activity faculty (that is, anyone in a position to control the content of the
education activity) disclose to the activity participants all relevant financial relationships with commercial interests.
Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve
University School of Medicine also requires that faculty make clinical recommendations based on the best
available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of
pharmaceutical products or medical devices.
DISCLOSURE OF THE FACULTY PRESENTING:
Drs. Corteville, Emery, Kalan, Knight, and Lucas reported no financial relationship relevant to this activity.
DISCLOSURE OF THE PLANNING COMMITTEE MEMBERS:
Drs. Reed and Slotta reported no financial relationship relevant to this activity.
HOW TO OBTAIN CREDIT FOR THIS CONFERENCE
•
•
•
•
•
We are pleased to announce that complimentary transcripts are available on-line through the CME Program
website at: http://casemed.case.edu/cme/
Please go to the Credit Transcript button on the left-hand side of the page, click on it, and follow the prompts
for Online Transcripts.
We hope you will find this feature helpful in keeping track of the number of AMA PRA Category 1 Credits™ you
have through the CME Program office.
Credits normally appear within 30-45 days after attendance at a conference.
Physicians and nurses alike can view their credits on file with the CME Program through this website. If you
have any problems viewing your transcript, please call the CME Program at 216-983-1239.
ACKNOWLEDGEMENTS
We gratefully acknowledge Cadence, Natura, Shionogi, and Sequenom Pharmaceuticals for their support of this
program.